JILLIAN SCHWARZ: Open Payments
NPI 1356037766 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 27 payments from 15 companies in 2025. Trend: 2023 $586 · 2024 $703 · 2025 $657
Food & beverage: $558Education: $99
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 5 | $189 |
| PFIZER INC. | 4 | $88 |
| Amgen Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Ethicon US, LLC | 1 | $34 |
| Philips North America LLC | 1 | $33 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| LeMaitre Vascular, Inc. | 1 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| United Therapeutics Corporation | 1 | $29 |
Products named: OPSUMIT, UPTRAVI, REPATHA, VYNDAQEL, WAINUA, ELIQUIS, STRATAFIX, Ambulatory Monitoring & Diagnostics Undivided.
Industry payments across ND — which companies pay providers there.
